Q2 2017 13F Holders as of 6/30/2017
-
Type / Class
-
Equity / COM
-
Number of holders
-
546
-
Total shares
-
214M
-
Shares change
-
+440K
-
Total reported value, excl. options
-
$26B
-
Value change
-
+$56.7M
-
Put/Call ratio
-
0.62
-
Number of buys
-
313
-
Number of sells
-
-241
-
Price
-
$121.67
Significant Holders of ALEXION PHARMACEUTICALS INC - COM (ALXN) as of Q2 2017
587 filings reported holding ALXN - ALEXION PHARMACEUTICALS INC - COM as of Q2 2017.
ALEXION PHARMACEUTICALS INC - COM (ALXN) has 546 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 214M shares
.
Largest 10 shareholders include PRICE T ROWE ASSOCIATES INC /MD/ (22.8M shares), FMR LLC (21.4M shares), BlackRock Inc. (19.9M shares), VANGUARD GROUP INC (14.8M shares), STATE STREET CORP (11.9M shares), BAKER BROS. ADVISORS LP (8.55M shares), SANDS CAPITAL MANAGEMENT, LLC (6.35M shares), AMERIPRISE FINANCIAL INC (6.18M shares), GOLDMAN SACHS GROUP INC (4.8M shares), and Invesco Ltd. (4.4M shares).
This table shows the top 546 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.